Naive patients
Showing 1 - 25 of 5,931
Twin Vaginal Delivery Skills Trial in Pescara (twin vaginal delivery simulation)
Recruiting
- Twin Vaginal Delivery Skills
- twin vaginal delivery simulation
-
Pescara, Italia, ItalyClaudio Celentano
Nov 6, 2023
Vitamin D Deficiency, Peripheral Neuropathy Trial (Vitamin D)
Not yet recruiting
- Vitamin D Deficiency
- Peripheral Neuropathy
- Vitamin D
- (no location specified)
May 2, 2023
Prostate Cancer Trial in Taoyuan (Multiparametric magnetic resonance imaging (mpMRI))
Active, not recruiting
- Prostate Cancer
- Multiparametric magnetic resonance imaging (mpMRI)
-
Taoyuan, TaiwanLi-Jen Wang
Nov 9, 2023
Sinus Rhythm Mapping in Pulmonary Vein Isolation Naive Atrial
Recruiting
- Atrial Fibrillation
- AI-enabled ECG score for Atrial Fibrillation (DNN score)
- Atrial voltage map in sinus rhythm
-
Genk, Limburg, BelgiumZiekenhuis Oost-Limburg
Oct 19, 2023
Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab Vedotin, Rituximab)
Recruiting
- Diffuse Large B Cell Lymphoma
- Zanubrutinib, Polatuzumab Vedotin, Rituximab
-
Shanghai, Shanghai, ChinaZhongshan Hospital,Fudan University
Jul 10, 2023
Diffuse Large B Cell Lymphoma Trial in Suzhou (Rituximab, Orelabrutinib, Pomalidomide)
Recruiting
- Diffuse Large B Cell Lymphoma
- Rituximab
- +4 more
-
Suzhou, Jiangsu, Chinathe First Affiliated Hospital of Soochow University
Apr 10, 2023
Schizophrenia Trial in Changsha (transcranial magnetic stimulation, sham stimulation)
Active, not recruiting
- Schizophrenia
- transcranial magnetic stimulation
- sham stimulation
-
Changsha, Hunan, ChinaCentral South University
Nov 16, 2022
Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)
Not yet recruiting
- Myelofibrosis
- Moderate Thrombocytopenia
- (no location specified)
Jul 31, 2023
Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive
Recruiting
- Non Muscle Invasive Bladder Cancer
- N803 plus Bacillus Calmette-Guerin (BCG)
-
Honolulu, HawaiiIsland Urology
Aug 7, 2023
Severe Aplastic Anemia Trial run by the NHLBI (Eltrombopag, Cyclosporine, Horse-Anti-thymocyte-Globulin)
Recruiting
- Severe Aplastic Anemia
- Eltrombopag
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Lung Cancer, NSCLC, Brain Metastases Trial (Alectinib, Stereotactic Radiosurgery)
Not yet recruiting
- Lung Cancer
- +2 more
- Alectinib
- Stereotactic Radiosurgery
- (no location specified)
Aug 4, 2023
Hiv, HIV-1-infection Trial in Buenos Aires (Lamivudine 300 MG, Emtricitabine / Tenofovir Disoproxil Pill)
Active, not recruiting
- Hiv
- HIV-1-infection
- Lamivudine 300 MG
- Emtricitabine / Tenofovir Disoproxil Pill
-
Buenos Aires, ArgentinaFundacion IDEAA
Jan 2, 2023
Urinary Bladder, Overactive Trial in Denizli (Transcutaneous tibial nerve stimulation (TTNS))
Not yet recruiting
- Urinary Bladder, Overactive
- Transcutaneous tibial nerve stimulation (TTNS)
-
Denizli, TurkeyPamukkale University
Dec 19, 2022
Healthy Volunteers Trial in Philadelphia (INO-A002, CELLECTRA® 2000, Dengue Fever Antibodies (IgG))
Completed
- Healthy Volunteers
- INO-A002
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Nov 7, 2022
Malaria Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Pvs230D1-EPA/Matrix-M)
Not yet recruiting
- Malaria
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 28, 2023
Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)
Not yet recruiting
- Non-Muscle- Invasive Bladder Cancer
- Durvalumab
- BCG
- (no location specified)
Jul 5, 2023
Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)
Active, not recruiting
- Non-muscle-invasive Bladder Cancer
- Gemcitabine 1000 mg, Docetaxel 37.5g
-
Zagreb, CroatiaUniversity Hospital Centre Zagreb
Jan 20, 2023
Helicobacter Pylori Infection Trial in New York (Amoxicillin, Omeprazole, Clarithromycin)
Completed
- Helicobacter Pylori Infection
- Amoxicillin
- +2 more
-
New York, New YorkMount Sinai Union Square Division of Digestive Diseases
Jan 6, 2023
Severe Aplastic Anemia Trial in Tianjin (Hetrombopag Olamine+Standard Therapy, Placebo+Standard Therapy)
Recruiting
- Severe Aplastic Anemia
- Hetrombopag Olamine+Standard Therapy
- Placebo+Standard Therapy
-
Tianjin, Tianjin, ChinaBlood Diseases Hospital, Chinese Academy of Medical Sciences
Jul 28, 2022
Merkel Cell Carcinoma Trial in Milano, Siena, Verona (Pembrolizumab, Etoposide, Cisplatin or Carboplatin)
Not yet recruiting
- Merkel Cell Carcinoma
- Pembrolizumab, Etoposide, Cisplatin or Carboplatin
-
Milano, Italy
- +2 more
Oct 10, 2023
HIV-1-infection Trial (Low-dose STP0404 (Pirmitegravir), Medium-dose STP0404 (Pirmitegravir), High-dose STP0404 (Pirmitegravir))
Not yet recruiting
- HIV-1-infection
- Low-dose STP0404 (Pirmitegravir)
- +3 more
- (no location specified)
May 16, 2023